Thermo Fisher Scientific (TMO) Form 3 THERMO FISHER SCIENTIFIC / Michael D Shafer ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Shafer Michael D

(Last) (First) (Middle)

168 THIRD AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/23/2024

3. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	16,696.3352	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	02/26/2026	Common Stock	8,475	253.99	D
Stock Option (Right to Buy)	(2)	09/05/2026	Common Stock	2,250	294.02	D
Stock Option (Right to Buy)	(3)	02/25/2027	Common Stock	11,200	309.63	D
Stock Option (Right to Buy)	03/09/2024	09/09/2027	Common Stock	14,300	418.32	D
Stock Option (Right to Buy)	(4)	02/23/2028	Common Stock	8,425	458.81	D
Stock Option (Right to Buy)	(5)	02/23/2030	Common Stock	7,698	528.58	D
Stock Option (Right to Buy)	(6)	02/22/2031	Common Stock	7,419	548.4	D
Stock Option (Right to Buy)	(7)	02/21/2032	Common Stock	9,077	552.85	D

Explanation of Responses:

1. The options vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.

2. The options vested in four equal annual installments on September 5, 2020, 2021, and 2022. The remaining one-quarter will vest on September 5, 2023.

3. The options vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.

4. The options vest in four equal annual installments. Three-quarters of the options vested on February 23, 2022, 2023, and 2024. The remaining one-quarter will vest on February 23, 2025.

5. The options vest in four equal annual installments. Two-quarters of the options vested on February 28, 2023 and 2024, and the remaining two-quarters will vest on February 28, 2025 and 2026.

6. The options vest in four equal annual installments. One-quarter of the options vested on February 28, 2024, and the remaining three-quarters will vest on February 28, 2025, 2026 and 2027.

7. The options vest in four equal annual installments on February 28, 2025, 2026, 2027 and 2028.

	/s/ Melodie T. Morin, Attorney-in-Fact for Michael D. Shafer	05/02/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.